DnB Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,048
| Closed | -$577K | – | 768 |
|
|
2025
Q1 | $577K | Buy |
9,048
+2,361
| +35% | +$151K | ﹤0.01% | 647 |
|
|
2024
Q4 | $813K | Sell |
6,687
-3,719
| -36% | -$452K | ﹤0.01% | 642 |
|
|
2024
Q3 | $1.3M | Buy |
10,406
+5,212
| +100% | +$651K | 0.01% | 620 |
|
|
2024
Q2 | $820K | Sell |
5,194
-347
| -6% | -$54.8K | ﹤0.01% | 634 |
|
|
2024
Q1 | $717K | Buy |
+5,541
| New | +$717K | ﹤0.01% | 639 |
|
|
2021
Q4 | – | Sell |
-27,293
| Closed | -$2.52M | – | 683 |
|
|
2021
Q3 | $2.52M | Buy |
+27,293
| New | +$2.52M | 0.02% | 495 |
|
|
2021
Q2 | – | Sell |
-38,014
| Closed | -$2.83M | – | 650 |
|
|
2021
Q1 | $2.83M | Buy |
38,014
+7,085
| +23% | +$528K | 0.02% | 466 |
|
|
2020
Q4 | $5.27M | Buy |
30,929
+18,422
| +147% | +$3.14M | 0.05% | 256 |
|
|
2020
Q3 | $1.76M | Sell |
12,507
-899
| -7% | -$126K | 0.02% | 422 |
|
|
2020
Q2 | $2.15M | Buy |
13,406
+2,758
| +26% | +$442K | 0.03% | 366 |
|
|
2020
Q1 | $1.04M | Sell |
10,648
-94
| -0.9% | -$9.2K | 0.02% | 474 |
|
|
2019
Q4 | $1.39M | Buy |
+10,742
| New | +$1.39M | 0.01% | 527 |
|